Colinz Laboratories Limited Declares Non-Applicability of SEBI Regulations for Quarter Ended March 2026
Colinz Laboratories Limited announced that Regulation 32 of the SEBI (LODR) Regulations, 2015, concerning the statement of deviation or variation for proceeds from public issues, rights issues, preferential issues, or Qualified Institutional Placements (QIPs), is not applicable for the quarter ended March 31, 2026. The company stated that this is because it did not undertake any public issue, rights issue, preferential issue, or QIP during the period.The company's BSE Code is 531-210. Colinz Laboratories Limited’s CIN is L24200MH1986PLC041120.
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.